Following Professor France Ashcroft’s 2015 damehood, Atreyi Chakrabarty examines how the work of one woman transformed both treatment and understanding of a debilitating childhood disease. Neonatal diabetes is a myth. At least that was what Frances Ashcroft was told in 1997 on her quest to find newborns with the condition. Yet her persistence and determination to find the cause and cure of this unique condition was unfailing. Not only did she
Rebecca Richmond-Smith investigates the new kid on the block in medical research. THE GENERATION of induced pluripotent stem cells is circumnavigating ethical issues normally associated with the production of embryonic stem cells while allowing innovative research. These ethical issues are to do with when the onset of human personhood is. The reprogramming of somatic cells to produce induced pluripotent stem cells avoids the ethical problems specific to embryonic stem cell research.